Figure 2.

Distribution of interferon-γ ELISpot response to peptides spanning the SARS-CoV-2 S1 and S2 spike protein subunits.

Analysis conducted in the CMI analysis population (N=50). The CMI analysis population comprised all participants who received a first dose of study vaccine and had at least one post-vaccination CMI assessment available for outcome/endpoint evaluation. Boxes and horizontal bars denote IQR and median ID50, respectively. Whisker endpoints are equal to the maximum and minimum values below or above the median ± 1.5 x IQR. CMI=cell-mediated immune; ELISpot=enzyme-linked immunospot; ID50=50% infective dose; IQR=interquartile range.